This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 05/11/2021
Location: Virtual
Subject: Listening Session with the Council for Responsible Nutrition
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Andrea Wong, Brian Wommack, Megan Olsen, Steve Mister (Council for Responsible Nutrition);

Event Date: 05/12/2021
Location: Virtual
Subject: Reagan-Udall Foundation for the Food and Drug Administration Annual Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, media, government, and other registered guests

Event Date: 05/12/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 05/13/2021
Location: Virtual
Subject: Updates on Pfizer Vaccine Emergency Use Authorization
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stakeholders from healthcare organizations, local and state health officials

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/12/2021
Location: Virtual
Subject: 2021 Virtual Food Safety Summit
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from the food industry, academia, and federal, state, and local regulatory organizations

Event Date: 05/13/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/10/2021
Location: Virtual
Subject: University of Southern California (USC) / Children's Hospital Los Angeles (CHLA) Cell Therapy Program Seminar Series; Facilitating the Development of Cellular Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 05/11/2021
Location: Washington, DC
Subject: Update from Federal Officials on Efforts to Combat COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Senate Health, Education, Labor and Pension (HELP) Committee members and staffs

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 05/11/2021
Location: Virtual
Subject: National Center for Toxicological Research (NCTR) Science Advisory Board
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, and other government agencies

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event